Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Open
RFA-AI-28-031Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is seeking applications for the Centers for Structural Biology of HIV and Other Infectious Diseases under solicitation RFA-AI-28-031. This funding opportunity aims to establish multidisciplinary consortia comprising structural biologists, microbiologists, and other experts dedicated to solving complex biological structures to advance the prevention, treatment, and cure of HIV and various other infectious diseases. Selected centers are expected to foster new collaborations, manage shared resources, and provide essential services to the broader research community while training future scientists in the field. The response deadline for this solicitation is May 29, 2027, and clinical trials are not allowed under this specific grant.

General Info

NIAID seeks multidisciplinary consortia for structural biology research on HIV and infectious diseases.

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyNational Institutes Of Health → National Institute Of Allergy And Infectious Diseases
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
The purpose of this notice of funding opportunity (NOFO) is to support multidisciplinary consortia of structural biologists, microbiologists, and associated experts to solve complex biological structures related to the prevention, treatment, and cure of HIV and other infectious diseases. Centers are expected to facilitate new collaborations, leverage shared resources, offer services and resources to the research community, and train the next generation of scientists engaged in structural biology of infectious diseases.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Grant
UKRI translation: MRC proof of concept: stage one
Solicitation # 195588
The UKRI Translation: MRC Proof of Concept (MRC PoC) stage one solicitation, managed by the Medical Research Council, seeks to translate UK discovery research into medical impact. The program focuses on progressing technology readiness levels from early-stage research toward clinical application, specifically supporting the development and testing of diagnostics, biomarker validation, and radiotherapy or radiation protocols. Eligible applicants must be research organizations such as universities, research institutes, or NHS bodies, though project partners may be based outside the UK if necessary. The solicitation follows a two-step decision process where stage one applications are reviewed by a panel, and successful candidates proceed to stage two for external peer review and further panel evaluation. Applications are evaluated based on clinical need, competitive advantage, the strength of the supporting rationale, deliverability, and the strategy for intellectual property and downstream development. Proposals must include a detailed 17-section project description, including an exit strategy and long-term development plan, while adhering to strict word counts. While there are no fixed upper limits on individual project funding or duration, the overall annual program budget is approximately 42 million pounds. Successful projects submitted by the November 18, 2026, deadline are expected to start between June and November 2027. Key requirements include the assembly of a multidisciplinary team with clinical, technical, and statistical expertise, and adherence to quality standards such as GLP or GMP for cell and gene therapy manufacturing.
Medical Research Council (MRC)

POSTED

3 days ago

DEADLINE

in 4 months
View Details
NAICS: 541714
New
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Solicitation # W911SR-26-R-HEAL
The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is establishing the Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) ecosystem. This continuous, open announcement seeks to build a network of pre-qualified partners to accelerate the development, testing, and fielding of next-generation medical defense solutions. The program focuses on two primary pillars: host-targeted resilience, which targets critical host systems like neurological and respiratory pathways to enhance physiological protection, and threat-targeted neutralization, which focuses on broad-spectrum countermeasures for prophylaxis and acute treatment. Priority is given to candidates designed for austere environments, featuring environmental stability without cold-chain reliance and simplified administration routes such as oral or intranasal delivery. The government is inviting two types of participants: MCM Development Collaborators, ranging from Phase I products through FDA licensure, and MCM Development Support Collaborators, such as CROs and CDMOs specializing in preclinical testing, cGMP manufacturing, and regulatory submissions. Interested parties must submit a white paper of no more than five pages detailing their product descriptions, efficacy data, regulatory status, and manufacturing capabilities. Acceptance into the PBA enables the subsequent award of project orders under the authority of 10 U.S.C sections 4021, 4022, and 4023. These agreements are not subject to the Competition in Contracting Act of 1984. All prospective awardees must be registered in the System for Award Management (SAM) database to receive payment.
W6QK Acc-Apg

POSTED

4 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Federal
DNA Sequencing Service
Solicitation # 75N98027Q00090
The National Institutes of Health (NIH) is soliciting a Firm Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract for high-throughput DNA sequencing services, including Sanger DNA sequencing and whole-plasmid sequencing. The scope of work involves processing plasmid DNA, genomic DNA, and PCR-generated material, with requirements for PCR amplification, product purification, and DNA normalization. The contractor is responsible for providing all sample collection and shipping materials, maintaining strict confidentiality of sequencing data, and retaining DNA samples for at least 180 days post-sequencing. Deliverables include specific electronic file formats such as .ab1, .fasta, and raw FASTQ data, alongside a Monthly Status Report submitted to the Contracting Officer's Representative (COR). The contract spans a five-year period from January 4, 2027, to January 3, 2032, with a total estimated value ranging from $184,200.00 to $958,584.20. Performance and delivery are centered at the NIEHS facility in Research Triangle Park, North Carolina. Award selection will be based on a best value tradeoff, where technical capability and past performance are weighted more heavily than price. Technical evaluations will focus on sequencing capability, personnel qualifications, quality assurance/control, and data management. The acquisition is not set aside for small businesses and falls under NAICS code 541714.
National Institutes Of Health Olao

POSTED

4 days ago

DEADLINE

in 16 days
View Details

More opportunities from National Institutes Of Health → National Institute Of Allergy And Infectious Diseases

Same awarding agency

Get AI-powered intelligence on this solicitation and the ones like it

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 900+ contractors already using CLEATUS